131 related articles for article (PubMed ID: 18566481)
1. 2-tier bacterial and in vitro selection of active and methotrexate-resistant variants of human dihydrofolate reductase.
Fossati E; Volpato JP; Poulin L; Guerrero V; Dugas DA; Pelletier JN
J Biomol Screen; 2008 Jul; 13(6):504-14. PubMed ID: 18566481
[TBL] [Abstract][Full Text] [Related]
2. Increasing methotrexate resistance by combination of active-site mutations in human dihydrofolate reductase.
Volpato JP; Fossati E; Pelletier JN
J Mol Biol; 2007 Oct; 373(3):599-611. PubMed ID: 17868689
[TBL] [Abstract][Full Text] [Related]
3. Selectively weakened binding of methotrexate by human dihydrofolate reductase allows rapid ex vivo selection of mammalian cells.
Volpato JP; Mayotte N; Fossati E; Guerrero V; Sauvageau G; Pelletier JN
J Mol Recognit; 2011; 24(2):188-98. PubMed ID: 21360609
[TBL] [Abstract][Full Text] [Related]
4. Allelic variation in the dihydrofolate reductase gene at amino acid position 95 contributes to antifolate resistance in Chinese hamster cells.
Yu M; Melera PW
Cancer Res; 1993 Dec; 53(24):6031-5. PubMed ID: 8261418
[TBL] [Abstract][Full Text] [Related]
5. Dihydrofolate reductase binding and cellular uptake of nonpolyglutamatable antifolates: correlates of cytotoxicity toward methotrexate-sensitive and -resistant human head and neck squamous carcinoma cells.
Chen G; Wright JE; Rosowsky A
Mol Pharmacol; 1995 Oct; 48(4):758-65. PubMed ID: 7476904
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of resistance to antifolates, a review.
Banerjee D; Ercikan-Abali E; Waltham M; Schnieders B; Hochhauser D; Li WW; Fan J; Gorlick R; Goker E; Bertino JR
Acta Biochim Pol; 1995; 42(4):457-64. PubMed ID: 8852336
[TBL] [Abstract][Full Text] [Related]
7. Drug-resistant dihydrofolate reductases: generation, expression and therapeutic application.
McIvor RS
Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S50-4. PubMed ID: 8971409
[TBL] [Abstract][Full Text] [Related]
8. Understanding the role of Leu22 variants in methotrexate resistance: comparison of wild-type and Leu22Arg variant mouse and human dihydrofolate reductase ternary crystal complexes with methotrexate and NADPH.
Cody V; Luft JR; Pangborn W
Acta Crystallogr D Biol Crystallogr; 2005 Feb; 61(Pt 2):147-55. PubMed ID: 15681865
[TBL] [Abstract][Full Text] [Related]
9. Drosophila dihydrofolate reductase mutations confer antifolate resistance to mammalian cells.
Affleck JG; Al-Batayneh KM; Neumann K; Cole SP; Walker VK
Eur J Pharmacol; 2006 Jan; 529(1-3):71-8. PubMed ID: 16325803
[TBL] [Abstract][Full Text] [Related]
10. Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate.
Diddens H; Niethammer D; Jackson RC
Cancer Res; 1983 Nov; 43(11):5286-92. PubMed ID: 6225514
[TBL] [Abstract][Full Text] [Related]
11. Protection of CCRF-CEM human lymphoid cells from antifolates by retroviral gene transfer of variants of murine dihydrofolate reductase.
Mareya SM; Sorrentino BP; Blakley RL
Cancer Gene Ther; 1998; 5(4):225-35. PubMed ID: 9694074
[TBL] [Abstract][Full Text] [Related]
12. Selection for methotrexate resistance in mammalian cells bearing a Drosophila dihydrofolate reductase transgene: Methotrexate resistance in transgenic mammalian cells.
Affleck JG; Nowickyj SM; Walker VK
Cell Biol Toxicol; 2010 Apr; 26(2):117-26. PubMed ID: 19337845
[TBL] [Abstract][Full Text] [Related]
13. In Silico Study Identified Methotrexate Analog as Potential Inhibitor of Drug Resistant Human Dihydrofolate Reductase for Cancer Therapeutics.
Rana RM; Rampogu S; Abid NB; Zeb A; Parate S; Lee G; Yoon S; Kim Y; Kim D; Lee KW
Molecules; 2020 Jul; 25(15):. PubMed ID: 32752079
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate preconditioning allows sufficient engraftment to confer drug resistance in mice transplanted with marrow expressing drug-resistant dihydrofolate reductase activity.
Belur LR; James RI; May C; Diers MD; Swanson D; Gunther R; McIvor RS
J Pharmacol Exp Ther; 2005 Aug; 314(2):668-74. PubMed ID: 15857949
[TBL] [Abstract][Full Text] [Related]
15. Active site-directed double mutants of dihydrofolate reductase.
Ercikan-Abali EA; Mineishi S; Tong Y; Nakahara S; Waltham MC; Banerjee D; Chen W; Sadelain M; Bertino JR
Cancer Res; 1996 Sep; 56(18):4142-5. PubMed ID: 8797582
[TBL] [Abstract][Full Text] [Related]
16. Dihydrofolate reductase mutant with exceptional resistance to methotrexate but not to trimetrexate.
Pineda P; Kanter A; McIvor RS; Benkovic SJ; Rosowsky A; Wagner CR
J Med Chem; 2003 Jul; 46(14):2816-8. PubMed ID: 12825924
[TBL] [Abstract][Full Text] [Related]
17. In silico screening against wild-type and mutant Plasmodium falciparum dihydrofolate reductase.
Fogel GB; Cheung M; Pittman E; Hecht D
J Mol Graph Model; 2008 Apr; 26(7):1145-52. PubMed ID: 18037315
[TBL] [Abstract][Full Text] [Related]
18. Towards understanding the mechanisms of molecular recognition by computer simulations of ligand-protein interactions.
Verkhivker GM; Rejto PA; Bouzida D; Arthurs S; Colson AB; Freer ST; Gehlhaar DK; Larson V; Luty BA; Marrone T; Rose PW
J Mol Recognit; 1999; 12(6):371-89. PubMed ID: 10611647
[TBL] [Abstract][Full Text] [Related]
19. A simple dual selection for functionally active mutants of Plasmodium falciparum dihydrofolate reductase with improved solubility.
Japrung D; Chusacultanachai S; Yuvaniyama J; Wilairat P; Yuthavong Y
Protein Eng Des Sel; 2005 Oct; 18(10):457-64. PubMed ID: 16120637
[TBL] [Abstract][Full Text] [Related]
20. In vitro mutations in dihydrofolate reductase that confer resistance to methotrexate: potential for clinical application.
Blakley RL; Sorrentino BP
Hum Mutat; 1998; 11(4):259-63. PubMed ID: 9554740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
